{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:29:02Z","timestamp":1764332942800,"version":"3.46.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32 HL105323","K23-HL-150301","K23 HL140199","R01-HL-164758"],"award-info":[{"award-number":["T32 HL105323","K23-HL-150301","K23 HL140199","R01-HL-164758"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K23-AR-075112"],"award-info":[{"award-number":["K23-AR-075112"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH2210163"],"award-info":[{"award-number":["W81XWH2210163"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-025-03395-3","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:17:36Z","timestamp":1764332256000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antiphospholipid antibodies and subclinical interstitial lung disease in the MESA cohort"],"prefix":"10.1186","volume":"26","author":[{"given":"Claire F.","family":"McGroder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary M.","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Newell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jubal","family":"Watts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Hrudaya","family":"Nath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushilkumar K.","family":"Sonavane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh","family":"Raghu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Graham","family":"Barr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna J.","family":"Podolanczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine Kim","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elana J.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"3395_CR1","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ccm.2004.05.009","volume":"25","author":"C Strange","year":"2004","unstructured":"Strange C, Highland KB. Interstitial lung disease in the patient who has connective tissue disease. Clin Chest Med. 2004;25:549\u201359.","journal-title":"Clin Chest Med"},{"key":"3395_CR2","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1164\/rccm.200607-912OC","volume":"175","author":"JH Park","year":"2007","unstructured":"Park JH, Kim DS, Park IN, Jang SJ, Kitaichi M, Nicholson AG, et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med. 2007;175:705\u201311.","journal-title":"Am J Respir Crit Care Med"},{"key":"3395_CR3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(12)61079-4","volume":"380","author":"A Fischer","year":"2012","unstructured":"Fischer A, Bois R. Interstitial lung disease in connective tissue disorders. Lancet. 2012;380:689\u201398.","journal-title":"Lancet"},{"key":"3395_CR4","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/ana.410260312","volume":"26","author":"SR Levine","year":"1989","unstructured":"Levine SR, Welch KM. Antiphospholipid antibodies. Ann Neurol. 1989;26:386\u20139. https:\/\/doi.org\/10.1002\/ana.410260312.","journal-title":"Ann Neurol"},{"key":"3395_CR5","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.humimm.2006.02.026","volume":"67","author":"CM Magro","year":"2006","unstructured":"Magro CM, Waldman WJ, Knight DA, Allen JN, Nadasdy T, Frambach GE, et al. Idiopathic pulmonary fibrosis related to endothelial injury and antiendothelial cell antibodies. Hum Immunol. 2006;67:284\u201397.","journal-title":"Hum Immunol"},{"key":"3395_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12931-018-0831-y","volume":"19","author":"S Kato","year":"2018","unstructured":"Kato S, Inui N, Hakamata A, Suzuki Y, Enomoto N, Fujisawa T, et al. Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis. Respir Res. 2018;19:127.","journal-title":"Respir Res"},{"key":"3395_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00259-004-1663-1","volume":"32","author":"N Takabatake","year":"2005","unstructured":"Takabatake N, Arao T, Sata M, Abe S, Inoue S, Shibata Y, et al. Involvement of pulmonary endothelial cell injury in the pathogenesis of pulmonary fibrosis: clinical assessment by 123I-MIBG lung scintigraphy. Eur J Nucl Med Mol Imaging. 2005;32:221\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3395_CR8","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1164\/rccm.202505-1054ST","volume":"211","author":"AJ Podolanczuk","year":"2025","unstructured":"Podolanczuk AJ, Hunninghake GM, Wilson KC, Khor YH, Kheir F, Pang B, et al. Approach to the evaluation and management of interstitial lung abnormalities: an official American thoracic society clinical statement. Am J Respir Crit Care Med. 2025;211:1132\u201355. https:\/\/doi.org\/10.1164\/rccm.202505-1054ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"3395_CR9","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.acra.2008.12.024","volume":"16","author":"EA Hoffman","year":"2009","unstructured":"Hoffman EA, Jiang R, Baumhauer H, Brooks MA, Carr JJ, Detrano R, et al. Reproducibility and validity of lung density measures from cardiac CT Scans\u2013The Multi-Ethnic study of atherosclerosis (MESA) lung study. Acad Radiol. 2009;16:689\u201399.","journal-title":"Acad Radiol"},{"key":"3395_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1164\/rccm.201809-1652OC","volume":"200","author":"RK Putman","year":"2019","unstructured":"Putman RK, Gudmundsson G, Axelsson GT, Hida T, Honda O, Araki T, et al. Imaging patterns are associated with interstitial lung abnormality progression and mortality. Am J Respir Crit Care Med. 2019;200:175\u201383. https:\/\/doi.org\/10.1164\/rccm.201809-1652OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"3395_CR11","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1183\/13993003.00129-2016","volume":"48","author":"AJ Podolanczuk","year":"2016","unstructured":"Podolanczuk AJ, Oelsner EC, Barr RG, Hoffman EA, Armstrong HF, Austin JH, et al. High Attenuation areas on chest computed tomography in community-dwelling adults: the MESA study. Eur Respir J. 2016;48:1442\u201352.","journal-title":"Eur Respir J"},{"key":"3395_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.acra.2009.07.016","volume":"17","author":"GR Washko","year":"2010","unstructured":"Washko GR, Lynch DA, Matsuoka S, Ross JC, Umeoka S, Diaz A, et al. Identification of early interstitial lung disease in smokers from the COPDGene study. Acad Radiol. 2010;17:48\u201353.","journal-title":"Acad Radiol"},{"key":"3395_CR13","doi-asserted-by":"publisher","unstructured":"Guo J, Reinhardt JM, Kitaoka H, Zhang L, Sonka M, McLennan G et al. Integrated system for CT-based assessment of parenchymal lung disease. Proceedings IEEE International Symposium on Biomedical Imaging. pp. 871\u20134. https:\/\/doi.org\/10.1109\/ISBI.2002.1029398.","DOI":"10.1109\/ISBI.2002.1029398"},{"key":"3395_CR14","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1109\/42.929615","volume":"20","author":"S Hu","year":"2001","unstructured":"Hu S, Hoffman EA, Reinhardt JM. Automatic lung segmentation for accurate quantitation of volumetric X-ray CT images. IEEE Trans Med Imaging. 2001;20:490\u20138.","journal-title":"IEEE Trans Med Imaging"},{"key":"3395_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJMoa0808836","volume":"362","author":"RG Barr","year":"2010","unstructured":"Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med. 2010;362:217\u201327.","journal-title":"N Engl J Med"},{"key":"3395_CR16","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/aje\/kwf113","volume":"156","author":"DE Bild","year":"2002","unstructured":"Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, et al. Multi-Ethnic study of atherosclerosis: objectives and design. Am J Epidemiol. 2002;156:871\u201381.","journal-title":"Am J Epidemiol"},{"key":"3395_CR17","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/art.10187","volume":"46","author":"R Cervera","year":"2002","unstructured":"Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al. Antiphospholipid syndrome: clinical and Immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46:1019\u201327.","journal-title":"Arthritis Rheum"},{"key":"3395_CR18","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","volume":"74","author":"R Cervera","year":"2015","unstructured":"Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, Ramon E, et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis. 2015;74:1011\u20138.","journal-title":"Ann Rheum Dis"},{"key":"3395_CR19","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/rheumatology\/33.10.977","volume":"33","author":"H Savin","year":"1994","unstructured":"Savin H, Huberman M, Kott E, Lishner M, Kitai Y, Kidron D, et al. Fibrosing alveolitis associated with primary antiphospholipid syndrome. Br J Rheumatol. 1994;33:977\u201380.","journal-title":"Br J Rheumatol"},{"key":"3395_CR20","first-page":"806","volume":"30","author":"T Barnini","year":"2012","unstructured":"Barnini T, Silvestri E, Emmi G, D\u2019Elios MM, Beccastrini E, Squatrito D, et al. Pulmonary fibrosis and lymphocytic alveolitis associated with triple antiphospholipid antibody positivity: a diagnostic puzzle. Clin Exp Rheumatol. 2012;30:806.","journal-title":"Clin Exp Rheumatol"},{"key":"3395_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1006\/jaut.2000.0396","volume":"15","author":"J Rauch","year":"2000","unstructured":"Rauch J, Subang R, D\u2019Agnillo P, Koh JS, Levine JS. Apoptosis and the antiphospholipid syndrome. J Autoimmun. 2000;15:231\u20135.","journal-title":"J Autoimmun"},{"key":"3395_CR22","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1513\/AnnalsATS.202012-1557OC","volume":"18","author":"JS Kim","year":"2021","unstructured":"Kim JS, Anderson MR, Bernstein EJ, Oelsner EC, Raghu G, Noth I, et al. Associations of D-Dimer with computed tomographic lung Abnormalities, serum biomarkers of lung Injury, and forced vital capacity: MESA lung study. Ann Am Thorac Soc. 2021;18:1839\u201348.","journal-title":"Ann Am Thorac Soc"},{"key":"3395_CR23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/qjmed\/hcu012","volume":"107","author":"S Barratt","year":"2014","unstructured":"Barratt S, Millar A. Vascular remodelling in the pathogenesis of idiopathic pulmonary fibrosis. QJM. 2014;107:515\u20139.","journal-title":"QJM"},{"key":"3395_CR24","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1164\/rccm.2403006","volume":"169","author":"EA Renzoni","year":"2004","unstructured":"Renzoni EA. Neovascularization in idiopathic pulmonary fibrosis: too much or too little? Am J Respir Crit Care Med. 2004;169:1179\u201380.","journal-title":"Am J Respir Crit Care Med"},{"key":"3395_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1465-9921-14-56","volume":"14","author":"YY Wan","year":"2013","unstructured":"Wan YY, Tian GY, Guo HS, Kang YM, Yao ZH, Li XL, et al. Endostatin, an angiogenesis inhibitor, ameliorates bleomycin-induced pulmonary fibrosis in rats. Respir Res. 2013;14:56.","journal-title":"Respir Res"},{"key":"3395_CR26","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S1474-4422(09)70239-X","volume":"8","author":"RT Urbanus","year":"2009","unstructured":"Urbanus RT, Siegerink B, Roest M, Rosendaal FR, Groot PG, Algra A. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol. 2009;8:998\u20131005.","journal-title":"Lancet Neurol"},{"key":"3395_CR27","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1161\/01.STR.29.11.2245","volume":"29","author":"P Verro","year":"1998","unstructured":"Verro P, Levine T, SR GE. Cerebrovascular ischemic events with high positive anticardiolipin antibodies. Stroke. 1998;29:2245\u201353.","journal-title":"Stroke"},{"key":"3395_CR28","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1111\/j.1538-7836.2007.02763.x","volume":"5","author":"PL Meroni","year":"2007","unstructured":"Meroni PL, Peyvandi F, Foco L, Bernardinelli L, Fetiveau R, Mannucci PM, et al. Anti-beta 2 glycoprotein I antibodies and the risk of myocardial infarction in young premenopausal women. J Thromb Haemost. 2007;5:2421\u20138.","journal-title":"J Thromb Haemost"},{"key":"3395_CR29","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMra1112830","volume":"368","author":"B Giannakopoulos","year":"2013","unstructured":"Giannakopoulos B, Krilis SA. The pathogenesis of the antiphospholipid syndrome. N Engl J Med. 2013;368:1033\u201344.","journal-title":"N Engl J Med"},{"key":"3395_CR30","doi-asserted-by":"publisher","first-page":"15541","DOI":"10.1074\/jbc.275.20.15541","volume":"275","author":"K Ma","year":"2000","unstructured":"Ma K, Simantov R, Zhang JC, Silverstein R, Hajjar KA, McCrae KR. High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by Annexin II. J Biol Chem. 2000;275:15541\u20138.","journal-title":"J Biol Chem"},{"key":"3395_CR31","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.18632\/oncotarget.375","volume":"2","author":"PA Madureira","year":"2011","unstructured":"Madureira PA, Hill R, Miller VA, Giacomantonio C, Lee PW, Waisman DM. Annexin A2 is a novel cellular redox regulatory protein involved in tumorigenesis. Oncotarget. 2011;2:1075\u201393.","journal-title":"Oncotarget"},{"key":"3395_CR32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1164\/rccm.200812-1966OC","volume":"180","author":"DJ Lederer","year":"2009","unstructured":"Lederer DJ, Enright PL, Kawut SM, Hoffman EA, Hunninghake G, Beek EJ, et al. Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic study of atherosclerosis (MESA)-lung study. Am J Respir Crit Care Med. 2009;180:407\u201314.","journal-title":"Am J Respir Crit Care Med"},{"key":"3395_CR33","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic pulmonary fibrosis (an Update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022;205:e18\u201347. https:\/\/doi.org\/10.1164\/rccm.202202-0399ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"3395_CR34","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1136\/ard.2005.038448","volume":"64","author":"I Uthman","year":"2005","unstructured":"Uthman I, Khamashta M. Ethnic and geographical variation in antiphospholipid (Hughes) syndrome. Ann Rheum Dis. 2005;64:1671\u20136.","journal-title":"Ann Rheum Dis"},{"key":"3395_CR35","doi-asserted-by":"crossref","unstructured":"Maningding E, Dall'Era M, Trupin L, Murphy LB, Yazdany J. Racial and Ethnic Differences in the Prevalence and Time to Onset of Manifestations of Systemic Lupus Erythematosus: The California Lupus Surveillance Project. Arthritis Care Res (Hoboken). 2020;72(5):622-9.","DOI":"10.1002\/acr.23887"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03395-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03395-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03395-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:17:37Z","timestamp":1764332257000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-025-03395-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3395"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03395-3","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. The study was approved by the Institutional Review Boards at each of the six enrolling centers and all participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare the following competing interests: CFM sits on advisory board for Avalyn Pharma. AJP reports research funding from NHLBI and the American Lung Association, receives consulting fees from Boehringer Ingelheim, Regeneron, and Imvaria and received honoraria from the National Association of Continuing Education. RGB reports research funding from the NIH and COPD Foundation, and receives consulting fees from the Environmental Protection Agency and the American Lung Association. GR receives grant funding from the NIH, consulting fees from Boehringer Ingelheim, BellerophanBlade Therapeutics, Bristol Myers Squibb, Gilead, Electra Therapeutics, Fibrogen, Nitto, Veracyte, Zambon, Roche-Genentech, royalties from UpToDate and sits on advisory boards for Avalyn Pharma and the Pulmonary Fibrosis Foundation. EJH receives grant funding from the NIH, sits on an advisory board for Siemens Healthineers and has stock options in VIDA Diagnostics. JK receives grant funding from NHLBI, Chest, and Pulmonary Fibrosis Foundation. MS received consulting fees from Boehringer Ingelheim, and Genentech, honoraria from Genentech, France Foundation, and Peer View. JW received honoraria from Boehringer Ingelheim. CKG reports grant funding from NIH and DOD. JDN reports receiving grant funding from NIH, consulting fees, honoraria, stocks and patents from VIDA Diagnostics and royalties and honoraria from Elsevier. SS reports receiving grant funding from NIH.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"340"}}